Structural requirements for the binding of tRNA3Lys to reverse transcriptase of the human immunodeficiency virus type 1

被引:0
|
作者
机构
来源
J. Biol. Chem. | / 40卷 / 23867-23874期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
    Kennedy, Edward M.
    Gavegnano, Christina
    Nguyen, Laura
    Slater, Rebecca
    Lucas, Amanda
    Fromentin, Emilie
    Schinazi, Raymond F.
    Kim, Baek
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (50) : 39380 - 39391
  • [42] Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1
    Herschhorn, A
    Admon, A
    Hizi, A
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2003, 1648 (1-2): : 154 - 163
  • [43] Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations
    Basavapathruni, Aravind
    Vingerhoets, Johan
    de Bethune, Marie-Pierre
    Chung, Raymond
    Bailey, Christopher M.
    Kim, Jiae
    Anderson, Karen S.
    BIOCHEMISTRY, 2006, 45 (23) : 7334 - 7340
  • [44] Properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection
    Sakuragi, Sayuri
    Shioda, Tatsuo
    Sakuragi, Jun-ichi
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 3382 - 3388
  • [45] Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine
    Lennerstrand, J
    Stammers, DK
    Larder, BA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2144 - 2146
  • [46] Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor
    Pilon, AA
    Lum, JJ
    Sanchez-Dardon, J
    Phenix, BN
    Douglas, R
    Badley, AD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2687 - 2691
  • [47] Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate
    QuinonesMateu, ME
    Soriano, V
    Domingo, E
    MenendezArias, L
    VIROLOGY, 1997, 236 (02) : 364 - 373
  • [48] Inhibition of human immunodeficiency virus type 1 reverse transcriptase by degradation products of ceftazidime
    Baertschi, SW
    Cantrell, AS
    Kuhfeld, MT
    Lorenz, LJ
    Boyd, DB
    Jaskunas, SR
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04): : 353 - 362
  • [49] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats
    Chang, M
    Sood, VK
    Wilson, GJ
    Kloosterman, DA
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 228 - 242
  • [50] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236